Novel Muscle Therapeutics Through Selective Beta-Adrenoceptor Signalling

Abstract

Muscle wasting is an urgent and unmet health risk commonly associated with ageing; cancer, muscle diseases, and conditions including cardiovascular and metabolic disorders. Manipulating beta-adrenergic signalling is a therapeutic target for muscle wasting but treatments have so far been limited due to cardiaovascular side effects. Using cutting edge technologies, we will identify treatments that effectively separate beneficial effects on skeletal muscles from unwanted effects on the heart.

Related publications (1)

Functional beta-Adrenoceptors Are Important for Early Muscle Regeneration in Mice through Effects on Myoblast Proliferation and Differentiation

Jarrod E Church, Jennifer Trieu, Radhika Sheorey, Annabel Y-M Chee, Timur Naim, Dale M Baum, James G Ryall, Paul Gregorevic, Gordon S Lynch

2014-07-07